US Stock MarketDetailed Quotes

CRVO CervoMed

Watchlist
  • 2.330
  • +0.140+6.39%
Close Feb 14 16:00 ET
  • 2.360
  • +0.030+1.29%
Post 20:01 ET
19.23MMarket Cap-1.61P/E (TTM)

About CervoMed Company

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.

Company Profile

SymbolCRVO
Company NameCervoMed
Listing DateNov 9, 2016
Founded1995
CEODr. John J. Alam, M.D.
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address20 Park Plaza,Suite 424
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02216
Phone1-617-744-4400

Company Executives

  • Name
  • Position
  • Salary
  • Dr. John J. Alam, M.D.
  • Chief Executive Officer, President and Director
  • 815.16K
  • William R. Elder
  • General Counsel, Corporate Secretary, Chief Financial Officer and Principal Accounting Officer
  • 468.35K
  • Dr. Robert Joseph Cobuzzi, Jr,PhD
  • Chief Operating Officer and Director
  • 703.12K
  • Kelly Blackburn
  • Senior Vice President, Clinical Development
  • 465.74K
  • Dr. Joshua S. Boger,PhD
  • Chairman of the Board
  • --
  • Dr. Sylvie Gregoire,Pharm.D.
  • Director
  • 376.94K
  • Jeffrey V. Poulton
  • Independent Director
  • 47.20K
  • Dr. Marwan Noel Sabbagh, M.D.
  • Independent Director
  • 41.15K
  • Frank Zavrl
  • Independent Director
  • 47.76K
  • Jane H. Hollingsworth
  • Independent Director
  • 82.91K

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More